Volume 17, Number 6—June 2011
Dispatch
Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
Diana Averbuch, Carlos Hidalgo-Grass, Allon E. Moses, Dan Engelhard, and Ran Nir-Paz
Table
Clinical information of patients positive for Mycoplasma pneumoniae, according to macrolide resistance genotype, Israel, 2010
| Characteristic | Macrolide-sensitive M. pneumoniae, n = 19* | Macrolide-resistant M. pneumoniae, n = 9 |
|---|---|---|
| Mean age, y, ± SD | 7 ± 14.98 | 9 ± 8.39 |
| >21 |
3 |
1 |
| Admission, mean d, ± SD | 4 ± 6.6 | 3 ± 8.2 |
| Pneumonia confirmed by chest radiograph |
16 |
9 |
| Male/female | 6/13 | 4/5 |
| Ethnicity (Arab/Jewish) |
5/14 |
1/8 |
| Complications† | 3 | 0 |
| Concurrent conditions‡ |
4 |
2 |
| Prior antibiotic use | 9 | 6 |
| Prior macrolide use | 3 | 2 |
*Values are no. patients except as indicated. Clinical data were not available for 2 patients.
†Two patients had Stevens-Johnson syndrome, and Still’s disease developed in 1 patient.
‡Four patients had asthma, 1 had metabolic syndrome with cardiomyopathy, and 1 had carcinoma of the pancreas.
1These authors contributed equally to this article.
